Manuscripts
January 10, 2023
Challenges to using big data in cancer
Cancer Research
Sweeney SM et al
January 10, 2023
Case studies for overcoming challenges in using big data in cancer
Cancer Research
Sweeney SM et al
May 1, 2022
Reaching beyond maximum grade: Progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
The Lancet Haematology
Thanarajasingam G et al
February 22, 2022
Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ study
Breast Cancer Research and Treatment
Miller RS et al
September 24, 2021
Survival in the real world: A national analysis of patients treated for early-stage breast cancer
JCO Oncology Practice
Gidwani R et al
April 28, 2022
Cancer registry data linkage of electronic health record data from ASCO's CancerLinQ: Evaluation of advantages, limitations, and lessons learned
JCO Clinical Cancer Informatics
Charlton M et al
October 4, 2021
Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
The Journal for ImmunoTherapy of Cancer
Heilbroner SP et al
October 18, 2021
The Friends of Cancer Research Real World Data (RWD) Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
Clinical Pharmacology & Therapeutics
Rivera D et al
February 21, 2021
Challenges and Opportunities to Developing a Frailty Index Using Electronic Health Record Data
Journal of Geriatric Oncology
Levit L et al
Abstracts
June 2, 2023
Evaluating clinical trial inclusion/exclusion criteria from claims using generative artificial intelligence
ASCO Annual Meeting 2023
Mueller J et al
June 2, 2023
Identification of biomarkers for early progression in muscle invasive bladder cancer (MIBC) using real-world data
ASCO Annual Meeting 2023
Singh N et al
June 2, 2023
Electronic health record (EHR)-based machine learning (ML) to predict disease recurrence after surgical resection of early-stage non-small cell lung cancer (eNSCLC)
ASCO Annual Meeting 2023
Pisano S et al
June 2, 2023
Assessment of electronic health record (EHR)-based machine learning (ML) in predicting risk of brain metastasis among patients with early-stage non-small-cell lung cancer (eNSCLC)
ASCO Annual Meeting 2023
Honarvar H et al
June 2, 2023
Biomarker testing and treatment patterns in US patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) harboring MET amplification
ASCO Annual Meeting 2023
Ryder A et al
June 2, 2023
Treatment outcomes in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) harboring MET amplification as a secondary oncogenic driver
ASCO Annual Meeting 2023
Ryder A et al
May 7, 2023
Patient characteristics, treatment patterns, and factors of biomarker testing among patients with advanced non-small cell lung cancer (ANSCLC) in the US, 2012-2020
ISPOR 2023
Yang M et al
May 1, 2023
Association of clinical trial enrollment and mortality amongst patients with advanced prostate cancer
AUA Annual Meeting 2023
Pessoa RR et al
April 30, 2023
Variation of hormonal agent usage with postoperative radiation therapy: Results from a population based cohort of prostate cancer patients in community oncology practices
AUA Annual Meeting 2023
Pessoa RR et al
